Presentation by Prof Lisa Askie, ANZCTR, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Dr Adrian Burton, ARDC, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
International perspective for sharing publicly funded medical research dataARDC
Presentation by Olivier Salvado, CSIRO, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Dr Davina Ghersi, NHMRC, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Dr Merran Smith, PHRN, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Hugo Leroux and Liming Zhu, CSIRO, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Kelly Hart, ONDC in PM&C, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Investigator-initiated clinical trials: a community perspectiveARDC
Presentation by Miranda Cumpston, ACTA, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Dr Steve McEachern, ADA, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Dr Adrian Burton, ARDC, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
International perspective for sharing publicly funded medical research dataARDC
Presentation by Olivier Salvado, CSIRO, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Dr Davina Ghersi, NHMRC, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Dr Merran Smith, PHRN, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Hugo Leroux and Liming Zhu, CSIRO, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Kelly Hart, ONDC in PM&C, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Investigator-initiated clinical trials: a community perspectiveARDC
Presentation by Miranda Cumpston, ACTA, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Dr Steve McEachern, ADA, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Sharing and standards christopher hart - clinical innovation and partnering...Christopher Hart
Acknowledging the increasing need for cooperation and collaboration in data sharing and access. Describing the complexity that this can bring. Then describing some of the ways to simplify that.
Originally presented at Terrapin's Clinical innovation and partnering world March 8-9 2017.
http://www.terrapinn.com/conference/innovation-and-partnering/index.stm
Kuchinke Clinical Trials Networks supported by tools and servicesWolfgang Kuchinke
Clinical Trials Networks supported by Tools and Services from Infrastructure Projects.
International clinical trials are a challenge to management. Though, the number of clinical trials worldwide is increasing by around 10% per year, approvals for new molecule entities and biomedical licenses show little long-term increase. Main challenges are the need to recruit and retain sufficient numbers of patients and the successful implementing e-Clinical Trials technologies, especially for trials incorporating ePRO (patient reported outcome) and eRecruitment services. We suggest that clinical trials networks should cooperate with infrastructure projects to enable the implementation of eTrials and patient-centric trials.
Clinical trials systems can be optimised by coordination through information sharing and collaboration and by building networks. Here infrastructures can function as enablers by the provision of
software tools, especially patient centric trials, ePRO (Patient Reported Outcome) and data collection and recruitment using EHRs (Electronic Health Records) and the implementation of nessessary data protection, privacy protection and identity management. As example for a clinical trials network ECRIN is addressed. ECRIN is a public, non-profit organisation that links scientific partners and networks across Europe to facilitate multinational clinical research. We suggest the integration of clinical research at ECRIN with several infrastructure services developed by BBMRI, EATRIS, EUDAT, TransForm, p-medicine, BioMedBridges, etc., resulting in an increase in interoperability of clinical data management, biobanking, genetic databases, Electronic Health Records (EHR), query systems, data warehouses, data repositories and imaging data.
ANDS health and medical data webinar 9 May. Review of the National Statement ...ARDC
Presentation by Jeremy Kenner from NHMRC on the review of the National Statement on Ethical Conduct in Human Research. Given on 9 May 2017
Full Webinar: https://www.youtube.com/watch?v=eENTF3oVVdk&t=2s
Transcript: https://www.slideshare.net/AustralianNationalDataService/transcript-webinar9517healthandmedicalshortbites
Informatics and Clinical Decision Support in Precision MedicineAndre Dekker
Talk given during http://www.miccai2015.org/ in Munich Germany. Part of the Satellite Workshop and Challenges in Imaging & Digital Pathology (https://wiki.cancerimagingarchive.net/x/JgM7AQ).
Closing the Loop in Healthcare Analytics - Correlating Clinical and Administrative Systems with Research Efforts to Deliver Clinical Efficiency in Real Time
January 23, 2017
The Fifth Annual Health Law Year in P/Review symposium featured leading experts discussing major developments during 2016 and what to watch out for in 2017. The discussion at this day-long event covered hot topics in such areas as health policy under the new administration, regulatory issues in clinical research, law at the end-of-life, patient rights and advocacy, pharmaceutical policy, reproductive health, and public health law.
The Fifth Annual Health Law Year in P/Review was sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Harvard Health Publications at Harvard Medical School, Health Affairs, the Hastings Center, the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund.
Learn more on our website: http://petrieflom.law.harvard.edu/events/details/5th-annual-health-law-year-in-p-review
Kraaij infrastructures for secure data analytics def brussel 2017Wessel Kraaij
How can we combine vertically partitioned data for data driven health in a secure way. Description of the Holland Health Data Cooperative and the Prana Data project www.pranadata.nl pilot on homomorphic encryption.
Contribution to the DigEnlight workshop https://digitalenlightenment.org/event/workshop-towards-european-ecosystem-health-care-data Oct 25 2017, Brussels.
Sharing and standards christopher hart - clinical innovation and partnering...Christopher Hart
Acknowledging the increasing need for cooperation and collaboration in data sharing and access. Describing the complexity that this can bring. Then describing some of the ways to simplify that.
Originally presented at Terrapin's Clinical innovation and partnering world March 8-9 2017.
http://www.terrapinn.com/conference/innovation-and-partnering/index.stm
Kuchinke Clinical Trials Networks supported by tools and servicesWolfgang Kuchinke
Clinical Trials Networks supported by Tools and Services from Infrastructure Projects.
International clinical trials are a challenge to management. Though, the number of clinical trials worldwide is increasing by around 10% per year, approvals for new molecule entities and biomedical licenses show little long-term increase. Main challenges are the need to recruit and retain sufficient numbers of patients and the successful implementing e-Clinical Trials technologies, especially for trials incorporating ePRO (patient reported outcome) and eRecruitment services. We suggest that clinical trials networks should cooperate with infrastructure projects to enable the implementation of eTrials and patient-centric trials.
Clinical trials systems can be optimised by coordination through information sharing and collaboration and by building networks. Here infrastructures can function as enablers by the provision of
software tools, especially patient centric trials, ePRO (Patient Reported Outcome) and data collection and recruitment using EHRs (Electronic Health Records) and the implementation of nessessary data protection, privacy protection and identity management. As example for a clinical trials network ECRIN is addressed. ECRIN is a public, non-profit organisation that links scientific partners and networks across Europe to facilitate multinational clinical research. We suggest the integration of clinical research at ECRIN with several infrastructure services developed by BBMRI, EATRIS, EUDAT, TransForm, p-medicine, BioMedBridges, etc., resulting in an increase in interoperability of clinical data management, biobanking, genetic databases, Electronic Health Records (EHR), query systems, data warehouses, data repositories and imaging data.
ANDS health and medical data webinar 9 May. Review of the National Statement ...ARDC
Presentation by Jeremy Kenner from NHMRC on the review of the National Statement on Ethical Conduct in Human Research. Given on 9 May 2017
Full Webinar: https://www.youtube.com/watch?v=eENTF3oVVdk&t=2s
Transcript: https://www.slideshare.net/AustralianNationalDataService/transcript-webinar9517healthandmedicalshortbites
Informatics and Clinical Decision Support in Precision MedicineAndre Dekker
Talk given during http://www.miccai2015.org/ in Munich Germany. Part of the Satellite Workshop and Challenges in Imaging & Digital Pathology (https://wiki.cancerimagingarchive.net/x/JgM7AQ).
Closing the Loop in Healthcare Analytics - Correlating Clinical and Administrative Systems with Research Efforts to Deliver Clinical Efficiency in Real Time
January 23, 2017
The Fifth Annual Health Law Year in P/Review symposium featured leading experts discussing major developments during 2016 and what to watch out for in 2017. The discussion at this day-long event covered hot topics in such areas as health policy under the new administration, regulatory issues in clinical research, law at the end-of-life, patient rights and advocacy, pharmaceutical policy, reproductive health, and public health law.
The Fifth Annual Health Law Year in P/Review was sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Harvard Health Publications at Harvard Medical School, Health Affairs, the Hastings Center, the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund.
Learn more on our website: http://petrieflom.law.harvard.edu/events/details/5th-annual-health-law-year-in-p-review
Kraaij infrastructures for secure data analytics def brussel 2017Wessel Kraaij
How can we combine vertically partitioned data for data driven health in a secure way. Description of the Holland Health Data Cooperative and the Prana Data project www.pranadata.nl pilot on homomorphic encryption.
Contribution to the DigEnlight workshop https://digitalenlightenment.org/event/workshop-towards-european-ecosystem-health-care-data Oct 25 2017, Brussels.
The Nuts & Bolts of Integrating Health Technology Assessment in Care Pathways...Brenda Rehaluk
This MA organizational change project was sponsored by the Alberta Health Services (AHS), Strategic Clinical Network, Health Technology Assessment and Adoption (SCN, HTAA) team. This research project's overarching question was on how can health technology assessment be used effectively in clinical care pathways and clinical practice guideline development.
Findings: Health technology assessment (HTA) creates a common language among health care providers to improve engagement and patient centred care. Optimization of health technology assessment involves the development of relationships, education, and simple technological tools to create a culture of HTA acceptance.
At the end of this presentation you will be able to:
Define evidence-based practice
Describe process & outline steps of EBP
Understand PICO elements & search strategy
Identify resources to support EBP
The focus of this presentation is nursing practice, although it is still of value to physicians and other health care professionals.
The Global Health Trials is a free, neutral network of communities of researchers, who are working together to share their knowledge about how to conduct research, so as to facilitate more research around the world and so improve health outcomes. It is for everyone, whatever your job role and wherever you are based, as long as you work in a Low or low-middle income country.
This workshop is meant to be an introduction to the systematic review process. Further information about systematic reviews was available through a research guide. http://libguides.ucalgary.ca/content.php?pid=593664
A Standards-based Approach to Development of Clinical Registries - Initial Le...Koray Atalag
This is the prezo I presented at HINZ 2014 conference.
Gestational diabetes has implications for both mother and child with risk of complications during pregnancy, and type 2 diabetes later in life. This paper presents the initial lessons learned from the development of a clinical registry. The aims of the Registry are: 1) 100% successful diabetes screening within 3 months of delivery; 2) Annual type 2 diabetes screening; 3) Early warning in subsequent pregnancies.
We have employed the openEHR standard which underpins our national interoperability reference architecture to represent the dataset and also to build the web-based registry system. Use of this rigorous methodology to tackle health information is expected to ensure semantic consistency of Registry data and maximise interoperability with other Sector projects. The development work has been facilitated by the ability to transform the dataset automatically into software code – ensuring clinical requirements accurately translated into technical terms.
Dataset has been finalised, registry system has been developed and deployed for pilot implementation. Data entry is underway for participants after consenting.
This registry is expected to increase the screening of women leading to earlier detection of diabetes. It should provide a valuable picture of the condition and is intended for extension and wider roll-out after evaluation.
Evidence to Care: Mobilizing Childhood Disability Research into Practice
Dr. Shauna Kingsnorth
Evidence to Care Lead
Clinical Study Investigator
Assistant Professor (status), Department of Occupational Science
and Occupational Therapy, University of Toronto
Holland Bloorview Kids Rehabilitation Hospital
skingsnorth@hollandbloorview.ca
Presented at: Canadian Knowledge Mobilization Forum
Saskatoon, Saskatchewan June 9, 2014
openEHR Approach to Detailed Clinical Models (DCM) Development - Lessons Lear...Koray Atalag
Presented at Health Informatics New Zealand (HINZ 2017) Conference, 1-3 Nov 2017, Rotorua, New Zealand. Based on my Masters student Peter Wei's research. Authorship: Ping-Cheng Wei, Koray Atalag and Karen Day from the University of Auckland.
Engage and Retain Patients in Long-term Observational StudiesJohn Reites
Traditionally, real-world and late phase studies require sites to enroll, engage and retain patients and collect and record patient reported outcomes (PRO), which can be burdensome to both sites and patients. Overtime, sites and patients may lose motivation to participate, contributing to high patient dropout rates, increased study costs and site dissatisfaction. This session will focus on innovative approaches for effectively engaging and retaining patients in long-term studies, such as: identifying design and operational considerations with conducting long-term observational research, understanding site and patient retention challenges, and examining engagement strategies and opportunities for improving retention and compliance.
How to handle discrepancies while you collect data for systemic review – pubricaPubrica
1. Population specification error:
2. Sample error:
3. Selection error:
4. Non- response error:
Continue Reading: https://bit.ly/36i7iYo
For our services: https://pubrica.com/services/research-services/systematic-review/
Why Pubrica:
When you order our services, We promise you the following – Plagiarism free | always on Time | 24*7 customer support | Written to international Standard | Unlimited Revisions support | Medical writing Expert | Publication Support | Biostatistical experts | High-quality Subject Matter Experts.
Contact us:
Web: https://pubrica.com/
Blog: https://pubrica.com/academy/
Email: sales@pubrica.com
WhatsApp : +91 9884350006
United Kingdom: +44-1618186353
Research Data Management Services at UWA (November 2015)Katina Toufexis
Research Data Management Services at the University of Western Australia (November 2015).
Created by Katina Toufexis of the eResearch Support Unit (University Library).
CC-BY
A standards-based approach to development of clinical registries - Initial lessons learnt from the gestational diabetes registry. Presented by Koray Atalag, National Institute for Health Innovation, University of Auckland, at HINZ 2014, 12 November 2014, 12pm, Plenary Room 2
Presentation by Prof Chris Rowe, ADNet, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
FAIR for the future: embracing all things dataARDC
FAIR for the future: embracing all things data - Natasha Simons, Keith Russell and Liz Stokes, presented at Taylor & Francis Scholarly Summits in Sydney 11 Feb 2019 and Melbourne 14 Feb 2019.
How to make your data count webinar, 26 Nov 2018ARDC
Slides from the 26 Nov Make your data count webinar. The research community has long grappled with the problem of assessing and tracking the results of scholarship. Research data is no exception. The Make Data Count (MDC) project (https://makedatacount.org/), funded by the Sloan Foundation, has delivered a data usage metric standard (Code of Practice) and a workflow for the retrieval and display of standardised usage and citation metrics in your repository interface.
Listen to this webinar to learn more about the Make Data Count project and the 5 steps you can take to make the data in your repository count. Hear from MDC project team members who have already implemented MDC in the dash (https://dash.ucop.edu) and DataOne (https://search.dataone.org/data) repositories. Learn from their experience, see the results.
Our international speaker line-up includes Daniella Lowenberg (California Digital Library) and Patricia Cruse (DataCite).
Recording available: https://youtu.be/Lkysz0Mc7fo
AFAIR in Astronomy Research - Slides. In this webinar ARDC is partnering with the ADACS project to explore the FAIR data principles in the context of Astronomy research and the ASVO and IVOA as a community exemplars of the implementation of the FAIR data principles.
These slides from: Keith Russell (ARDC): Looking at FAIR
In this talk Keith will provide an overview of the FAIR principles and how it was used in astronomy before it became official. He will conclude the talk by discussing what other disciplines can learn from their approach.
Slides from the Birds of a Feather presentation given by ARDC (Australian Research Data Commons) Acting Executive Director Ian Duncan at the 2018 eResearch conference in Melbourne.
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Normal Labour/ Stages of Labour/ Mechanism of LabourWasim Ak
Normal labor is also termed spontaneous labor, defined as the natural physiological process through which the fetus, placenta, and membranes are expelled from the uterus through the birth canal at term (37 to 42 weeks
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
1. Clinical trials data sharing
Prof Lisa Askie
Director, Systematic Reviews and Health Technology Assessment
NHMRC Clinical Trials Centre
University of Sydney, Australia
Co-convenor, Cochrane Prospective Meta-analysis Methods Group
Member, Cochrane Individual Participant Data Meta-analysis Methods Group
Manager, Australian New Zealand Clinical Trials Registry
Cochrane Review author
Clinical trialist
2.
3. About half of clinical trials conducted in Australia do not test drugs or devices and do not have industry involvement
4. 50% of research is not published
Lancet 2014;383:257–66
But similar across countries, size, phase, …
WASTE
9. UK results on data sharing attitudes
• In 2011 survey, 85% of researchers said they
thought their data would be of interest to
others
• Only 41% said they would be happy to make
their data available
• Only a third had previously published data
Source: DaMaRO Project, University of Oxford
http://www.slideshare.net/DigCurv/15-meriel-patrick
10. Current situation summary
• Known about publication bias and selective
outcome reporting for over 30 years
• Some (mostly US & European) legislation
‘requiring’ data sharing, mostly re drug trials
• Compliance with data sharing remains poor
• Recent calls for fully open, fully accessible clinical
trial datasets to be made available from all trials
11. *Simes RJ. Publication bias: the case for an international registry of clinical trials. J Clin Oncol. 1986
12. The University of Sydney Page 12
Prospective trial registration
Trial information on the ANZCTR and other Primary
registries is imported onto the WHO ICTRP Search
Portal
Available at www.who.int/trialsearch
22. Common problems with trial data
• inconsistent data coding both within (at
different time points) and across trials
• lack of a detailed and robust data dictionary
and/or meta-data
• data errors, inconsistencies with published
results - often unresolvable, MIA data manager
• different definitions of key outcomes
25. FAIR Guiding Principles for Scientific
Data Management and Stewardship
Findability
Accessibility
Interoperability
Reusability
26. Why curate my clinical trial data?
• costly, time consuming, ongoing resourcing
• no academic or commercial recognition
(in reality system penalises collaboration and
sharing)
• what incentives can be implemented?
29. Take home messages for trialists
• data needs to be curated for future use, not
just simply dumped or ‘shared’
• assume your trial data will be used by others
(with no control by you) in the future for
purposes not initially intended
• common definitions of key, core outcomes
would be very helpful
• well documented data dictionaries are crucial
• need repositories that can receive, curate,
provide access to clinical trial data using FAIR
principles
Editor's Notes
The second key issue is selective outcome reporting.
This refers to either:
non-reporting of pre-specified trial outcomes; or
reporting of non-pre-specified trial outcomes.
This study by An-Wen Chan and colleagues found that 50% of efficacy and 65% of harm outcomes per trial were incompletely reported, and that statistically significant outcomes had higher odds of being fully reported compared with non-significant outcomes.
However, the good news is that the US Department of Health and Human Services has recently decided to take a stronger stance on this and get tough on transparency. As of January 2017, those researchers not complying with mandatory results reporting may be subject to substantial fines, and may also have all future NIH grant funding withheld.
SOAR - Duke Clinical Research Institute
YODA – Yale
ACCESS – CVS
Project Data Sphere- Project Data Sphere, LLC (PDS), an independent, not-for-profit initiative of the CEO Roundtable on Cancer's Life Sciences Consortium (LSC), operates the Project Data Sphere platform, a free digital library-laboratory that provides one place where the research community can broadly share, integrate and analyze historical, patient-level data from academic and industry phase III cancer clinical trials.
Despite US legislation mandating results reporting for specific types of trials, compliance has been poor. This study by Prayle and colleagues found that only 22% of studies subject to mandatory results reporting actually complied.
Since 2005, the International Committee of Medical Journal Editors (known as ICMJE) has required authors to prospectively register their trials in order to be considered for publication in a member journal.
More recently, in January this year, the ICMJE issued a proposal to require that authors include a plan for data sharing as a component of clinical trial registration. Furthermore, they also propose that as a condition of consideration for publication in a member journal, authors must share with others the de-identified individual participant data underlying the results presented in the article no later than 6 months after publication.